Health Care - Spark Newswire

1 minute read

Protagonist Stock Moves Higher As Rusfertide Shows Durability Of Effect, Symptom Improvements In Blood Cancer Trial

Today, 7:28 AM

Protagonist Therapeutics Inc (NASDAQ:PTGX) has announced updated results from the ongoing Phase 2 study of rusfertide for polycythemia vera (PV), a…

PTGX

2 minute read

Chemomab Therapeutics Is Heating Up And Could See A Move Soon

By Tyler Bundy

Today, 7:28 AM

Chemomab Therapeutics LTD. (NASDAQ: CMMB) shares are trading higher Friday as retail traders continue to push stocks higher.

CMMB

1 minute read

Biden Admin. To Give Hospitals More Time To Spend COVID-19 Relief Money

By Benzinga Newsdesk

Today, 7:28 AM

-Dow Jones

IYH

2 minute read

A Technical Look At Novan’s Stock Amid 80% Spike

By Tyler Bundy

Today, 7:28 AM

Novan Inc. (NASDAQ: NOVN) shares are trading higher Friday after the company reported that B-SIMPLE4 pivotal Phase 3 trial of SB206 achieved significance for the primary endpoint with no adverse events.

NOVN

1 minute read

Vertex, Crispr Unveil More Encouraging Data From Sickle Cell, Thalassemia Gene Therapy Trials

By Vandana Singh

Today, 7:28 AM

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Crispr Therapeutics AG (NASDAQ:CRSP) have announced new data from Phase 1/2 clinical trials evaluating CTX001 in beta-thalassemia and…

CRSP

1 minute read

BeiGene Touts Initial Brukinsa Efficacy, Safety Profile For Leukemia, Compared To Imbruvica

By Vandana Singh

Today, 7:28 AM

BeiGene Ltd (NASDAQ:BGNE) revealed an interim analysis of the Phase 3 ALPINE trial evaluating Brukinsa (zanubrutinib) to Johnson & Johnson’s (NYSE:JNJ) Imbruvica (ibrutinib)…

BGNE

1 minute read

AbbVie-Roche’s Venclexta Shows Progression-Free Survival Of 74% In CLL Patients After Three Years Treatment

By Vandana Singh

Today, 7:28 AM

Genentech, a unit of Roche Holdings AG (OTC:RHHBY), and its collaborating partner AbbVie Inc (NYSE:ABBV) have announced long-term follow-up data from two Phase 3…

ABBV

1 minute read

Curis Shares Drop After Updated CA-4948 Data From Mid-Stage Blood Cancer Trial

By Vandana Singh

Today, 7:28 AM

Curis Inc (NASDAQ:CRIS) has announced updated data from its ongoing Phase 1/2 study of CA-4948 in patients with acute myeloid leukemia…

CRIS

1 minute read

Equillium’s Itolizumab Shows Rapid, Durable Responses In Graft-Versus-Host-Disease Patients

By Vandana Singh

Today, 7:28 AM

Equillium Inc (NASDAQ:EQ) has announced positive topline data from the Phase 1b EQUATE study evaluating itolizumab in first-line acute graft-versus-host-disease (aGVHD).…

1 minute read

Autolus Therapeutics’ CAR T Cell Achieves 100% Complete Remission In Indolent B Cell Non-Hodgkin Cohort

By Vandana Singh

Today, 7:28 AM

Autolus Therapeutics plc (NASDAQ:AUTL) has announced new data from AUTO1 (obecabtagene autoleucel, obe-cel) in relapsed / refractory (r/r) indolent B cell…

AUTL